戈谢病的治疗。 - Suppr

Suppr

超能文献

Treatment of Gaucher's disease.

作者信息

Hollak C E, Aerts J M, van Oers M H

出版信息

N Engl J Med. 1993 May 27;328(21):1565-6; author reply 1567.

PMID:8479498

Abstract

摘要

相似文献

Treatment of Gaucher's disease.

N Engl J Med. 1993 May 27;328(21):1565-6; author reply 1567.

Enzyme-replacement therapy for Gaucher's disease.

N Engl J Med. 1991 Dec 19;325(25):1809-11. doi: 10.1056/NEJM199112193252513.

Treatment of Gaucher's disease.

N Engl J Med. 1993 May 27;328(21):1564-5; author reply 1567-8.

[Enzyme therapy of Gaucher's disease].

Dtsch Med Wochenschr. 1993 Jun 25;118(25):964-5.

Ceredase dosing concerns for Gaucher's disease.

Am J Med. 1994 Oct;97(4):402-3. doi: 10.1016/0002-9343(94)90314-x.

Plasma lipoprotein responses to enzyme-replacement in Gaucher's disease.

Lancet. 1999 Feb 20;353(9153):642-3. doi: 10.1016/S0140-6736(99)00188-9.

Treatment regimens in Gaucher's disease.

Lancet. 1995 Aug 26;346(8974):581-2. doi: 10.1016/s0140-6736(95)91422-6.

Gaucher's disease: therapy by intravenous infusions of modified glucocerebrosidase.

Clin Investig. 1993 Jan;71(1):78. doi: 10.1007/BF00210974.

Imiglucerase treatment in Gaucher's disease.

J Ayub Med Coll Abbottabad. 2007 Apr-Jun;19(2):56-9.

Cerebroside-beta-glucosidase encapsulation in liposomes for Gaucher's disease treatment revisited.

Pharm Res. 1999 Mar;16(3):466-9. doi: 10.1023/a:1011998407862.

引用本文的文献

Glycoprotein Non-Metastatic Protein B: An Emerging Biomarker for Lysosomal Dysfunction in Macrophages.

Int J Mol Sci. 2018 Dec 24;20(1):66. doi: 10.3390/ijms20010066.

Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease.

Pharmacoeconomics. 1995 Jan;7(1):63-90. doi: 10.2165/00019053-199507010-00007.

Alglucerase for Gaucher's disease: dose, costs and benefits.

Pharmacoeconomics. 1994 Jun;5(6):453-9. doi: 10.2165/00019053-199405060-00001.

The effect of enzyme therapy in a patient with Gaucher disease type III.

J Inherit Metab Dis. 1996;19(5):703-4. doi: 10.1007/BF01799852.

Current issues in enzyme therapy for Gaucher disease.

Drugs. 1996 Aug;52(2):159-67. doi: 10.2165/00003495-199652020-00001.

Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.

J Clin Invest. 1994 Mar;93(3):1288-92. doi: 10.1172/JCI117084.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Treatment of Gaucher's disease.

N Engl J Med. 1993 May 27;328(21):1565-6; author reply 1567.

Enzyme-replacement therapy for Gaucher's disease.

N Engl J Med. 1991 Dec 19;325(25):1809-11. doi: 10.1056/NEJM199112193252513.

Treatment of Gaucher's disease.

N Engl J Med. 1993 May 27;328(21):1564-5; author reply 1567-8.

[Enzyme therapy of Gaucher's disease].

Dtsch Med Wochenschr. 1993 Jun 25;118(25):964-5.

Ceredase dosing concerns for Gaucher's disease.

Am J Med. 1994 Oct;97(4):402-3. doi: 10.1016/0002-9343(94)90314-x.

Plasma lipoprotein responses to enzyme-replacement in Gaucher's disease.

Lancet. 1999 Feb 20;353(9153):642-3. doi: 10.1016/S0140-6736(99)00188-9.

Treatment regimens in Gaucher's disease.

Lancet. 1995 Aug 26;346(8974):581-2. doi: 10.1016/s0140-6736(95)91422-6.

Gaucher's disease: therapy by intravenous infusions of modified glucocerebrosidase.

Clin Investig. 1993 Jan;71(1):78. doi: 10.1007/BF00210974.

Imiglucerase treatment in Gaucher's disease.

J Ayub Med Coll Abbottabad. 2007 Apr-Jun;19(2):56-9.

Cerebroside-beta-glucosidase encapsulation in liposomes for Gaucher's disease treatment revisited.

Pharm Res. 1999 Mar;16(3):466-9. doi: 10.1023/a:1011998407862.

引用本文的文献

Glycoprotein Non-Metastatic Protein B: An Emerging Biomarker for Lysosomal Dysfunction in Macrophages.

Int J Mol Sci. 2018 Dec 24;20(1):66. doi: 10.3390/ijms20010066.

Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease.

Pharmacoeconomics. 1995 Jan;7(1):63-90. doi: 10.2165/00019053-199507010-00007.

Alglucerase for Gaucher's disease: dose, costs and benefits.

Pharmacoeconomics. 1994 Jun;5(6):453-9. doi: 10.2165/00019053-199405060-00001.

The effect of enzyme therapy in a patient with Gaucher disease type III.

J Inherit Metab Dis. 1996;19(5):703-4. doi: 10.1007/BF01799852.

Current issues in enzyme therapy for Gaucher disease.

Drugs. 1996 Aug;52(2):159-67. doi: 10.2165/00003495-199652020-00001.

Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.

J Clin Invest. 1994 Mar;93(3):1288-92. doi: 10.1172/JCI117084.